Commentary · 21 Feb 2026
Conference abstractPublished 19 Sep 2016
Novel approach to target aggressive breast cancer cells using a cannabis compound
California Pacific Medical Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dysregulated expression of the transcriptional regulator, Id-1, leads to breast cancer progression and metastasis. Specifically, we found high levels of Id-1 in breast tumor biopsies from human patients with aggressive cancer. Ectopic expression of Id-1 in non-aggressive human cancer cells rendered them highly proliferative and invasive. Conversely, human breast cancer cell aggressiveness was decreased in culture by siRNA, shRNA or antisense RNA directed against the Id-1 gene. Next, we asked whether Id-1 could be exploited as a therapeutic target to treat metastatic cancers. Using tumor-bearing animals and nonviral systemic gene targeting technique, we showed that reduction of Id-1 levels significantly decreased the metastatic spread of breast cancer cells. Since Id-1 expression is scarce in most mature adult tissues, a majority of normal cells would not be affected by systemic therapy targeting this gene. We recently determined that the cannabinoid compound, cannabidiol (CBD), inhibited a program controlling tumor cell invasion and proliferation through down-regulation of Id-1 gene expression. We also discovered the ability of this non-psychoactive, non-toxic, cannabinoid to significantly reduce the metastatic spread of aggressive breast cancer cells in vivo. CBD is now available in medical marijuana dispensaries and is being used by cancer patients who are desperate to try novel approaches to treat their metastatic disease. Hopefully, CBD should become available for clinical trials within the next few years.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Pierre-Yves Desprez”
